Robbie Williams says his vision is worsening. The pop icon attributes this alarming change to his use of the weight-loss medication Mounjaro. He revealed this personal health scare in late 2025. His candid admission has ignited a crucial conversation about the potential side effects of so-called “skinny jabs.”
Blurry Vision and Growing Concerns
In interviews with The Sun, Williams described his experience as both baffling and alarming. “I was quite an early adapter of the jabs, but what I’m also noticing is that my eyesight’s not very good,” he admitted. The singer, now 51, says his vision has grown increasingly blurry over the past months.This affects both his daily life and performances. “It’s been blurry for a while now, and it’s only getting worse,” Williams stated. He firmly believes the medication, not age, is the cause. He recounted a moment at an American football game where the players appeared as indistinct blobs on the field.Williams also described difficulty seeing fans during his signature ‘She’s The One’ serenades. “I was looking in the direction of these women looking up at me, having this experience that’s quite obviously incredible to them, and little do they know I can’t see them,” he shared. He has since visited an optician, though he initially didn’t mention Mounjaro as a possible factor.

Mounjaro’s Manufacturer Responds
Mounjaro, a brand name for tirzepatide, is produced by pharmaceutical giant Eli Lilly. It gained fame as a powerful weight-loss aid in addition to its use for type 2 diabetes. Williams is far from alone in using such medications. Reports indicate nearly 2.5 million purchases of similar ‘skinny jabs’ occurred in July 2025 alone.Eli Lilly responded to the claims, emphasizing patient safety. The company stated it has ongoing discussions with regulators regarding potential safety issues. They continue to review all relevant data, including any concerning ophthalmic problems. Their official advice, reported by LBC, is for anyone experiencing side effects to consult their doctor immediately.Medical experts caution that the evidence remains inconclusive. Michael Burdon, a consultant at the Royal College of Ophthalmologists, explained the challenge. He noted reports of patients experiencing blood flow issues to the back of the eye, a condition called NAION. However, he said it is difficult to establish a direct causal link because both the drug use and the condition are common.Recent U.S. studies found patients using certain diabetes medications were up to four times more likely to develop NAION. A clear consensus on causality or the exact level of risk is still lacking. Burdon stressed the importance of medical supervision for anyone using this type of drug.
Balancing Physical and Mental Health
Despite the vision concerns, Williams says he is unlikely to stop the medication soon. He cites profound improvements in his mental health as the primary reason. “The lack of mental anguish that I’ve felt since I’ve been on Mounjaro is completely and utterly liberating,” he shared. For years, Williams has been open about his battles with depression and intrusive thoughts.This new outlook has translated into a disciplined fitness regimen. He described a daily routine of mobility work, dips, press-ups, and squats. His renewed focus on self-care even includes considering a facelift next year. Still, Williams remains starkly candid about the potential trade-offs he faces for his mental well-being.
Sara Cox Shatters Fundraising Records with 135-Mile Ultramarathon for Children in Need
Robbie Williams’ experience highlights a critical dilemma in modern healthcare. The pursuit of one health benefit can sometimes introduce new, unforeseen risks. His story serves as a powerful reminder for all patients to research thoroughly and maintain open communication with their doctors.
Thought you’d like to know-
What is Mounjaro primarily used for?
Mounjaro, or tirzepatide, is a medication approved for managing type 2 diabetes. It is also widely prescribed off-label for weight loss due to its potent effects on appetite and blood sugar regulation.
What specific eye condition is potentially linked to these drugs?
Some studies suggest a potential increased risk of a condition called NAION, or non-arteritic anterior ischemic optic neuropathy. This involves a loss of blood flow to the optic nerve and can lead to sudden vision loss.
Is the link between these jabs and vision loss proven?
No, a definitive causal link is not yet proven. Medical experts and regulatory bodies are actively reviewing the data. The current evidence is considered preliminary and requires more extensive research to confirm any connection.
Why does Robbie Williams continue using Mounjaro?
Williams continues the treatment because of the significant positive impact on his mental health. He has stated it has liberated him from mental anguish, a benefit he currently weighs as more important than the potential risk to his eyesight.
What should someone considering this medication do?
Anyone considering this type of medication should have a thorough discussion with a qualified healthcare professional. It is crucial to understand all potential benefits and risks, and to ensure usage is properly supervised by a doctor.
iNews covers the latest and most impactful stories across
entertainment,
business,
sports,
politics, and
technology,
from AI breakthroughs to major global developments. Stay updated with the trends shaping our world. For news tips, editorial feedback, or professional inquiries, please email us at
[email protected].
Get the latest news first by following us on
Google News,
Twitter,
Facebook,
Telegram
, and subscribe to our
YouTube channel.



